Effect of NMDA and IL-1β on neuron survival and NF-κB/Rel activation in CA1 region of hippocampal slices from C57BL/6 mice. After 15 min exposure to NMDA (100 µM ) hippocamapal slices were left to recover for 35 min in fresh buffer. Exposure to IL-1β (1000 U/ml) was maintained for the entire period (50 min).
(A) Immunohistochemistry and TUNEL-labelling in CA1 region of mouse hippocampal slices. Scale bar, 20 µm (B) Western blot analysis of p65 and c-Rel protein in nuclear extracts of hippocampal slices. The NMDA treatment increased the nuclear amount of p65 subunit, while IL-1β stimulation increased the nuclear levels of both p65 and c-Rel. Blots reprobed with an anti α-tubulin antibody indicated equal amounts of proteins in the different lanes (data not shown). (C) Antibodies to NeuN (Cy-2 green) and c-Rel or p65 (both Cy-3 red) demonstrate colocalization. The nuclear localization of NF-κB proteins shows that NMDA stimulation activates only p65 subunit, while IL-1β exposure promotes nuclear translocation of both p65 and c-Rel proteins IL-1β (1000 U/ml) elicits neuroprotection against NMDA (100 µM)-mediated excitotoxicity in hippocampal slices from wild-type mice (WT), but exerts toxicity in slices from c-Rel -/-mice (c-Rel -/-). Quantitative analysis of NMDA and IL-1β-induced cell loss in CA1 hippocampal region of WT and c-Rel -/-mice. * P< 0.05 vs the corresponding values of WT group. Besides their well-established role in the immune system, chemokines also play a role in the central nervous system (CNS), not only in neuroinflammation, but also in neurodevelopment and possibly in the regulation of neurophysiological signalling (Biber et al., 2002) . We studied the possible effects exerted by the chemokines CCL5 (previously known as RANTES) and stromalcell-derived factor-1α (SDF-1α, CXCL12) in human neurons. Pure populations of postmitotic human NT2-N neurons were prepared by retinoic acid-induced differentiation of NTera2/D1 cells (Pleasure et al., 1992) . NT2-N neurons were shown to express CCR5 and CXCR4 chemokine receptors, as revealed by RT-PCR and immunocytochemistry. Contrary to undifferentiated cells, NT2-N neurons were dose-dependently responsive to either CCL5 and CXCL12 in a cell migration assay ( Fig. 1) .
GENE EXPRESSION PROFILE ACTIVATED BY THE CC CHEMOKINE LIGAND 5/RANTES IN HUMAN NEURONAL CELLS
Since most chemokine-mediated biological activities are likely due to the regulation of the expression of chemokine-responsive genes, the transcriptional program activated by exposing NT2-N neurons to CCL5 or CXCL12 for 2 or 8 hours was analyzed with the cDNA microarray technology. We used GF201 GeneFilters wich contain 5,184 genes or ESTs corresponding to i) known human genes; ii) genes similar to known genes in human or other organisms and iii) genes of completely unknown function. Only the data regarding CCL5 treatment have been analyzed up to now. We applied criteria described by Locati et al., 2001 , with minor modifications. Expression values of transcripts scoring as present (data values > 1.2 vs background and % of spot artifact removal <20) were normalized and compared. Transcripts with a ratio value of normalized expression levels between two different experimental conditions > 2.0 or < 0.5 were regarded as induced or decreased, respectively, in the single experiment under evaluation. We considered a gene as CCL5-responsive if it satisfied these criteria in at least 2 out of 3 independent experiments with different cell preparations and was not acting oppositely in the third experiment.
We observed consistent increases in transcript levels for 111 genes after the 2 hour CCL5 treatment in NT2-N neurons. Analyzing the 8 hour treatment, 5.4% of these genes scored as significantly upregulated by the chemokine; other genes were unchanged. None of expressed genes was found to be consistently inhibited by exposing NT2-N neurons to CCL5 for 2 or 8 hours. Results arising from cDNA arrays are being verified using real-time PCR. The cluster assessment allowed us to identify functional subsets of genes including receptors, enzymes and signaling regulators ( Fig. 2) , among others. Interestingly, the ESTs selected in this study encode several unknown genes that could represent potential novel targets for future study of chemokine action in the CNS. We are grateful CIB for financial support.
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Biber K, Zuurman MW, Dijkstra IM, Boddeke HW. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol. 2002; 2: 63-8 . Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, Mantovani A.
Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol. 2002; 168: 3557-62 . Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci. 1992; 12:1802-15. Here we report that a novel member of the TNF-α family, TNF-related apoptosis inducing ligand (TRAIL), contributes substantially to amyloid-induced neurotoxicity in human SH-SY5Y neuronal cell line.
Involvement of TRAIL in the amyloid-induced cell death is supported by cDNA array, Northen blot, and Western blot data, demonstrating increased TRAIL expression after treatment of the cells with a neurotoxic fragment of amyloid protein (βAP). TRAIL was also found to be released in the culture media after βAP treatment with a time-course overlapping to contents of the intracellular protein. Contribution of TRAIL to βAP neurotoxicity is demonstrated by data showing that TRAIL-neutralizing monoclonal antibody protects neuronal SH-SY5Y cells from βAP neurotoxicity. Moreover, exposure of neuronal SH-SY5Y cells to TRAIL leads to cell death, indicating that this substance per se is endowed with neurotoxic properties
We also found that, similarly to βAP and TRAIL, activation of the death domain adaptor protein FADD results in neuronal cell death. Lack of FADD function, by over-expression of its dominant negative, rescued cells from either TRAIL-, or βAP-induced neurotoxicity, supporting the hypothesis that these three molecules share common intracellular pathways. Finally, we found that βAP strongly activated caspase 8 and the cell-permeable, selective caspase-8 inhibitor z-IETD-FMK prevents both βAP-and TRAIL-induced neurotoxicity.
In view of TRAIL's potency in inducing neuronal death, and of its role as mediator of βAP, it is plausible to hypothesize that TRAIL can be regarded as a molecule that provides substantial contribution to βAP-dependent cell death which takes part in the progression of the neurodegenerative process and related chronic inflammatory response.
Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J. Effects of TRAIL and anti-TRAIL neutralizing antibody on cell viability. Cells were exposed for 48 h to 25 µM βAP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] or 100 µg/ml TRAIL in the presence or absence of the anti-TRAIL neutralizing antibody (α-TRAIL) as indicated, and then apoptosis was evaluated. Upper panels show representative images of cells exposed to 25 µM βAP Schematic representation of β-AP mechanism of action. β-AP induces the increased of TRAIL and DR5 expression, both in term of mRNA and protein levels in SY5Y neuronal cells. Soluble TRAIL released in the media binds to its receptor DR5. The interaction TRAIL/DR5 activates an intracellular pathway that involves the recruitment of FADD and the activation of caspase 8. These events lead to apoptotic cell death. The significant of such effect is demonstrated by the evidences that anti-TRAIL neutralizing antibody, the over-expression of FADD dominant negative and the caspase 8 inhibitor z-IETD-FMK prevent β-AP induced apoptosis. The ability of NGF to activate the pituitary-adrenocortical axis, together with an increased serum NGF concentration in pregnancy and lactation, gives support to the hypothesis of NGF as a modulator of endocrine functions, identifying the pituitary gland as one of the possible sources of circulating NGF. Interestingly, in rats, NGF immunoreactivity is associated with intracellular structures very similar to the secretory granules labelled with prolactin (PRL) antibodies. The hypothesis of a direct correlation between PRL and NGF secretion has been strengthen by the finding that cell lines obtained from dopamine (DA)-sensitive prolactinomas, with a low level of malignancy and devoid of any tumorigenic activity in nude mice express high levels of both NGF messenger RNA and protein, which is secreted in the culture medium, endowed with biogical activity. On these basis, we verify whether in humans the pituitary gland could be a source of circulating NGF. We firstly measured serum NGF concentrations in normal men and women, in order to verify the possible involvement of sexual hormone in modulating serum NGF concentrations, by means of an ELISA approach. The ELISA performed in serum obtained from men indicated that NGF concentration was 40.8 ± 10.8 pg/ml, whereas women showed statistically significant lower levels, that were influenced by the menstrual cycle. In particular, the mean value of this neurotrophin during the follicular phase was 8.2 ± 1.4 pg/ml, while the luteal phase showed a significant increase of NGF levels up to 14.4 ± 2.9 pg/ml. Subsequently, four women diagnosed with secernent microprolactinoma were studied and our data indicate that prolactinoma patients showed markedly higher levels of serum NGF (60.3 ± 18.7 pg/ml) compared to normal women. Serum NGF concentration appears to be under a dopaminergic inhibitory control, as the medical therapy with the D-2 DA agonist cabergoline normalizes serum PRL concentrations and induces a parallel and significant decrease of serum NGF concentrations. Taken together, present data point out that serum NGF concentration is sex-related and indicate a possible role of sex steroids as modulators of NGF secretion in humans. Further, these results strongly suggest that NGF is secreted in the bloodstream from the pituitary gland, modulated by a DA-mediated mechanism. Psychoneuroimmunological studies strongly demonstrate that NGF could play a role as "alert" molecule in stressful conditions. Although a role of PRL in stress is still matter of discussion, evidence indicate that the well-characterized model of stress such as parachute jumping induced an increase of both NGF and PRL. A consensus regarding the precise role of PRL in the neuroimmune-endocrine system is still elusive, nevertheless it is intriguing the observation that NGF and PRL share numerous similarities in their pleiotropic functions. • Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera, A, Tirassa P (1994) Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc. Natl. Acad. Sci. USA 91: 10440-10444.
• Schedlowski M, Wiechert D, Wagner TO, Tewes U (1992) Acute psychological stress increases plasma levels of cortisol, prolactin and TSH. Life Sci 50: 1201-5. A recent publication reported that multipotent stem cells can be isolated from the dermis of mouse skin (Toma' J.G., Nature Cell Biology, 3,778-784 (2001) . These cells have been differentiated in culture to produce neurons, glia and smooth muscle. The aim of the present study is to confirm these observations and to expand them by characterizing the phenotype of the differentiated excitable cells, i.e., neurons, glia and muscular cells. For preparation of multipotent stem cells, C57Bl6 adult (1-3 months) and juvenile (3-21 days) mice were used. Cells were dissociated from the skin and cultured in medium containing epidermal grow factor (EGF) and basic fibroblast grow factor (bFGF). After 3-5 days many cells adhered to the plastic and differentiated while other cells formed small floating spheres. The spheres were mechanically dissociated to single cells every 4-5 days and passaged in fresh medium and grow factors generating new spheres. These cells into the spheres maintained an undifferentiated state. In our experience the spheres can be passaged up to four months. The undifferentiated cells were induced to differentiation true adhesion on poly-D-lysine/laminin coated coverslides in absence of grow factors. In order to characterise the differentiated cells immunostainings with different antibodies were performed. We have identified cells of mesenchymal origin, which are positively stained for fibronectin or vimentin, and also cells with neuronal phenotype. Twenty four hours after plating these cells were positive for nestin a marker for neuronal precursors. After 3 days of differentiation they expressed the neuron-specific βIII tubulin marker and, after 5 days some cells also expressed neurophilament-M (NFM). Cells with astrocytes and muscle markers were also identified. These observations indicate that stem cells derived from the dermis can be differentiated in various cell lineages, including cells expressing markers of neurons, astrocytes and muscle cells. We have developed two groups of human prolactinoma cell lines referred to as responder (R) and non responder (NR). "Responder" cells were obtained from bromocriptine-sensitive tumors and are more differentiated, non tumorigenic and express an autocrine loop mediated by nerve growth factor (NGF). Non responder cells were obtained from tumors refractory to the bromocriptine therapy and are more transformed, have a high tumorigenic potential and lack NGF production. We have reported that NGF administratrion to NR cells promotes their differentiation, induces the expression of D2 receptors and inhibits their proliferation rate. In this study we investigated the mechanisms mediating the antiproliferative action of NGF in NR prolactinomas. Cell proliferation is controlled by specific repressors. In particular an important restriction point in the G1 phase as been identified, that is controlled by p53 and p21 tumor suppressor proteins. We first evaluated whether p53 expression in NR cells is modified by NGF treatment. The results showed that p53 is highly expressed in NR cells and its levels are not modified by NGF treatment. Since p53 activation implies its nuclear translocation, p53 cellular localization was evaluated in R and NR cells by immunocitochemistry.
In NR p53 appears to be segregated in the cytoplasm, while in R cells it appears to be equally distributed in both the nucleus and the cytoplasm. Exposure of NR cells to NGF resulted in the redistribution of p53 to the nucleus and in the expression of p21 and Mdm2, two target genes of p53, suggesting that this treatment restores a functional p53-p21 pathway. In addition, the results show that NGF treatment significantly down-regulated cyclin A, Cyclin E and cdk2, suggesting that the antiproliferative effect of NGF in NR prolactinomas implies cell cycle arrest in G0/G1. The signal transduction pathway activated by NGF involves two different receptors: trkA and p75. With the aim of evaluating the role of these two different receptors in the antiproliferative effect of NGF we measured the action of NGF in the presence of specific inhibitors of the NGF receptors.
The results have shown that the antiproliferative effect of NGF is exclusively mediated by trkAinduced activation of PI-3 kinase.
Decker SJ ( Prostate growth and differentiation are regulated by interactions between androgens and peptide factors. Alterations in these pathways may contribute to the initiation and progression of prostate cancer. One paracrine/autocrine factor regulating prostate growth and differentiation is Nerve Growth Factor (NGF). The role of NGF and its receptors in the prostate, however, is still controversial. In our hands, NGF treatment of human prostate cancer cell lines reduced their tumorigenicity, both in vitro and in vivo. The aim of this study was then to investigate the involvement of NGF as differentiation factor in prostate cancer cells. Our results suggest that NGF could turn towards a differentiation pathway the androgen-independent/AR-negative DU145 prostate cancer cell line. When DU145 cells are exposed to NGF (50 ng/ml, 8 days), we observed a reversion of these cells to a slow proliferating phenotype with low telomerase activity, characterized by the reexpression of hallmarks of prostate cells, such as ARs and p75 NGFR . Reexpression of ARs restores the DHT sensitivity. When NGFtreated DU145 cells are cultured in serum-free medium, indeed, the addition of 10 nM DHT induces a marked increase of the cell proliferation rate. This effect was blocked by the antiandrogen hydroxyflutamide (HF, 10 µM). Interestingly, NGF-treated AR-positive DU145 cells undergone apoptosis following the pharmacological ablation of DHT induced by exposure to 10 µM HF (about 40% of apoptotic nuclei, detected either by Hoechst 3342 dying and TUNEL assay). The differentiation pathway activated by NGF induces also a significant reduction of the telomerase activity, through the inhibition of the telomerase catalytic subunit (hTERT) at the transcriptional level, as suggested by Northern blot, where a strong reduction of the 6.6Kb hTERT hybridization band could be detected in NGF-treated compared to untreated DU145 cells. Finally, we would like to stress the relevance of the NGF-mediated reexpression of p75 NGFR , because evidence has accumulated that an inverse association exists between this NGF receptor expression and the malignant progression of the prostate; as a matter of fact, p75 NGFR has been FR has been proposed as tumor suppressor gene for the prostate. 0.5µg/µl RNase for 30 min at 37°C of untreated cell extracts was performed as internal control. PCR amplification products were resolved on a 10% acrylamide gel and exposed to Kodak-X-Omat film. B: Northern blot: The expression of hTR and of the hTERT mRNA was investigated in untreated and NGF-treated DU145 cells. In each lane, 20 µg of total RNA were resolved on 1% agaroseformaldehyde gel, blotted onto nylon membrane and hybridized with the hTERT and hTR probes. Filters were washed twice for 15 min in 0.1x SSC/0.1% SDS at 55°C and exposed to film. Immunocytochemistry: NGF-treated DU145 cells were divided in two Petri dishes, one of which was treated with 10 nM DHT for three days, while the other was maintained in serum-free medium. AR expression was studied with the immunocytochemistry method described above. Panel a: NGF-treated cells in serum-free medium + 10 nM DHT; panel b: NGF-treated cells in serum-free medium. Magnification: 200x. D: Cell proliferation: NGF-treated DU145 cells were plated at the density of 50 x 10 3 in 24 well plates for direct cell counting. NGF-treated cells were maintained in serumfree medium or treated for three days with 10 nM DHT, or 10 nM DHT + 10 µM HF. For the direct counting with the hemocytometer, 5 fields for each treatment condition were counted, and counts were made in at least three separate experiments. Data are the means ± SE from three different experiments run in quadruplicate. Ghrelin is a 28 aminoacid acylated peptide isolated from mammalian stomach. It selectively stimulates the growth hormone secretagogue receptor. Ghrelin is expressed also in hypothalamic neurons and partecipates in the control of endocrine and extra-endocrine functions. Ghrelin causes an increase in food intake when administered either peripherally or intracerebroventricularly (icv) in rodents. Reportedly, the orexigenic effect of exogenous ghrelin is mediated by its action on the arcuate NPY/Agouti-related peptide neurons. In order to better characterize the role of the endogenous central tone of ghrelin in the regulation of feeding behavior, we first administered to adult male Sprague-Dawley satiated rats 40 µg/rat icv of anti-ghrelin rabbit immunoglobulins (IgG) of IgG purified from preimmune rabbit serum. Anti-ghrelin IgG induced a significant reduction of cumulative 24-hour food intake compared to preimmune IgG and the inhibitory effect lasted for 48 hours (mean inhibition ± SEM, 0-24-h: 20% ± 2%; 24-48-h: 16% ± 3%; P<0.05). As a second step, we injected unilaterally into the arcuate nucleus (ARC) of male Sprague-Dawley rats, 3 µg/rat of anti-ghrelin rabbit IgG. Controls received 1 µl of saline. Food intake was measured in the 24 hours following treatment. The immunoneutralization of ghrelin did not affect natural, dark phase food intake in rats; conversely, it significantly inhibited the starvation induced food intake during 2-as well as 6-hours following chow distribution (mean inhibition ± SEM, 0-2 h: 22.3% ± 4%; 0-6 h: 24.9% ± 3% vs saline, P<0.05). Since it has been reported that in rodents and humans ghrelin is synthetized primarily in the stomach and its serum concentrations are increased by starvation, we also evaluated the involvement of circulating ghrelin on feeding behavior. Adult male rats were injected intraperitoneally (ip) with 600 µl of rat anti-ghrelin antiserum or preimmune rabbit serum. Anti-ghrelin IgG inhibited the starvation induced food intake during 2 hours following chow distribution (mean inhibition ± SEM, 0-2 h: 20% ± 6%, P<0.05 vs preimmune IgG) without altering the cumulative food intake over 6 or 24 hours. These results indicate that ghrelin is an endogenous orexigenic peptide acting in the arcuate nucleus and circulating ghrelin may be directly involved in the control of the initial phase of food intake after fasting. Striatal medium spiny neurons express both D1 and D2 dopamine receptors and ionotropic glutamate receptors. In particular, D1 receptors are localized in neuronal spines, both in the spine shaft and in the spine head and in the post synaptic density (PSD), where NMDA receptors and their scaffolding proteins are co-clustered. The overlap in the subcellular distribution of NMDA and D 1 receptors and the observation that both D 1 and NMDA trafficking to synapses is dependent on glutamate transmission suggest that direct receptor-receptor interactions might occur. In this study, by using a combination of co-immunoprecipitation, pull-out with GST-fusion proteins and bioluminescence resonance energy trasnfer (BRET), we report that the D 1 receptor forms a heteromeric complex with the NMDA receptor. The D 1 receptor co-immunoprecipitated with NMDA receptor subunits from purified striatal PSD, suggesting that they are co-clustered in this structure. That this clustering reflects the existence of direct protein-protein interactions was demonstrated by BRET. A significant and specific BRET signal was found when D1 fused to Renilla luciferase (D1-Rluc) and NR1 fused to green fluorescent protein (NR1-GFP) were cotransfected in COS-7 cells. This interaction was insensitive to agonist stimulation. By using confocal microscopy we analysed HEK 293 cells transfected with D1 and NR1 either individually or simultaneously to identify the cellular compartment where D1 and NR1 are assembled. As previously reported when expressed alone NR1 was not target to the cell membrane and was accumulated in the perinuclear region and in the endoplasmic reticulum (ER). By contrast, the D1 receptor expressed in HEK293 cells was readily and completely targeted to the plasma membrane with no ER staining. When D1 and NR1 were co-expressed in the same cells, NR1 was delivered to the plasma membrane together with the D1 receptor suggesting that the two receptors are assembled as dimeric units in the ER and transported to the cell surface as a preformed complex.
NERVE GROWTH FACTOR INDUCES THE REEXPRESSION OF FUNCTIONAL ANDROGEN RECEPTORS

ENDOGENOUS GHRELIN IS AN OREXIGENIC PEPTIDE ACTING IN THE ARCUATE NUCLEUS IN RESPONSE TO FASTING
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Taken together these observations point to a constitutive, direct and selective interaction of D 1 with NR1. The importance of soluble receptor (sIL6-R) for interleukin-6 (IL-6) signalling in the nervous system has been recognized (Marz et al., 1999) . We investigated the effects of a chimeric protein (IL6RIL6 chimera) containing IL-6 fused to its sIL-6R on the proliferation and/or differentiation of rat oligodendrocyte progenitor cells (OPCs) and on oligodendrocyte survival. Exposure of OPCs to IL6RIL6 chimera for 48 hours induced a dose-dependent decrease of bromodeoxyuridine (BrdU) incorporation. IL6RIL6 chimera treatment for 48 h also strongly increased the reduction of the tetrazolium salt MTS by mitochondrial enzymes and enhanced oligodendrocyte staining with MitoTracker red, a fluorescent dye specifically labelling functionally active mitochondria (Simpson et al., 1997) . A strong, dose-dependent increase in the number and length of processes immunostained for early (galactocerebroside) or late (myelin basic protein) oligodendrocyte differentiation markers was revealed after OPC treatment with IL6RIL6 chimera, respectively for 2 or 7 days ( fig. 1 ). Moreover, treatment with IL6RIL6 chimera improved oligodendrocyte survival. The chimera-induced increase of oligodendrocyte arborization was mimicked, though with lower efficacy, by ciliary neurotrophic factor (CNTF) but not by IL-6 and was reduced in the presence of a gp130 soluble peptide which is able to inhibit the gp130-mediated signals of the IL-6/sIL-6R complex. Oligodendrocyte treatment with IL6RIL6 chimera for 30 min induced both the signal transducer and activator of transcription-1 (STAT-1) and STAT-3 phosphorylation and nuclear translocation ( fig. 2 ). Several target genes that are activated or repressed via STAT pathways by IL-6-type cytokines in various cellular models have been recently described (Heinrich et al., 1998) . Further research affording the transcriptional profile of IL6RIL6 chimera-treated oligodendrocytes in comparison to that of control cultures will provide valuable information on the genes involved in the progressive maturation of oligodendocytes from OPCs. We conclude that, by interacting with membrane gp130 and possibly by activating Janus kinase (JAK)/STAT pathways, IL6RIL6 chimera induces OPCs to differentiate into mature oligodendrocytes, promotes their survival and could deserve investigation as a therapeutic strategy for enhancing remyelination.
FIG. 1: in striatal neurons
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Heinrich PC, Behrmann I, Muller-Newen G, Schaper f and Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 1998; 334: 297-314.
Marz P, Otten U and Rose-John S. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci. 1999; 11: 2995-3004 .
Simpson PB, Mehotra S, Lange GD and Russell JT. High density distribution of endoplasmic reticulum proteins and mitochondria at specialized Ca 2+ release sites in oligodendrocyte processes. J. Biol. Chem. 1997; 272: 22654-22661 . Several of the genes and proteins that are associated with early neural development have recently be found to play central roles in Alzheimer's Disease (AD). The Notch proteins provide a useful example of such dual signalling. Notch family of proteins consists of at least four transmembrane receptors that control cell fate determination. Involvement of Notch proteins in AD have been suggested by the finding that both Notch1 and APP can be cleaved by a PS1-associated γ secretase activity and that Notch1 expression is markedly increased in AD hippocampal formation. Also, Notch3 gene mutations can lead to CADASIL, an adult-onset autosomal dominant neurological disease characterized by progressive subcortical infarcts and dementia. We focussed our study on Notch2. It has been shown that Notch2 mRNA is expressed during embryonic brain development. Furthermore, postnatal mouse brain strongly expresses Notch2 in hippocampus, temporal cortex, and cerebellum. We investigated on the expression of Notch2 in the hippocampus of mice after kainic acid (KA) injection (25 mg/Kg, i.p.). In hippocampus of control mice, Notch2 was predominantly present in the dentate gyrus with very little staining in CA1 field and CA2/3 region completely devoid of immunostaining. 24 h after KA injection, Notch2 immunoreactivity was dramatically increased in the CA1 region. 3 days after the lesion, a time-point when excitotoxic damage becomes apparent in vulnerable pyramidal neurons of CA3, several intact neurons in the CA3 field were intensively positive. Increased Notch2 immunoreactivity in CA1 and CA3 region was still evident 42 days after KA injection. Notch2 overexpression after KA treatment was confirmed by Western blot analysis showing increased Notch2 protein levels in hippocampus from experimental mice at 3 days after the treatment These results suggest additional roles of Notch2 receptor in maintenance of adult neurons and its involvement in the response to excitotoxic stimuli.
INCREASED NOTCH2 EXPRESSION IN HIPPOCAMPUS OF ADULT MOUSE AFTER KAINATE TREATMENT
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Sestan N., Artavanis-Tsakonas S. and Rakic P. Western blot analysis of Notch2 expression In hippocampus and cerebral cortex after kainic acid administration. Analysis was performed on protein extracts from hippocampus (1, 2) and cerebral cortex (3, 4) of mice treated with either saline (1, 3) or KA (2, 4) Ghrelin, an endogenous ligand for growth hormone (GH)-secretagogue receptors, has been detected in several tissues, including bone. We previously showed that a long-term treatment with Hexarelin, a highly selective synthetic GHsecretagogue which stimulates ghrelin receptors, prevented the bone loss induced by gonadectomy in adult rats ( Sibilia et al.1999; . To study whether Hexarelin directly acts on bone cells of the osteoblastic lineage, we examined the effect of the peptide on cell proliferation and differentiation in primary cultures of rat calvaria osteoblasts and in human osteoblast-like cells in culture. In the same experiments we compared the action of Hexarelin to that of ghrelin, the endogenous ligand of Hexarelin's receptors. Primary calvarial osteoblastic cells were obtained from 21-day old rat embryos and treated with ghrelin and Hexarelin at the concentration of 0,1-10nM for 24 hours at the sixth passage. Ghrelin as well as Hexarelin did not modify 3[H]-thymidine incorporation into DNA, an index of cell proliferation. Similar results were obtained in a cell line derived from a human osteosarcoma, SaOS-2, exposed to the same concentration of the peptides. On the contrary, both ghrelin and Hexarelin significantly increased the production of alkaline phosphatase (ALP) and osteocalcin, indexes of osteoblastic differentiation and activation, in calvarial osteoblast ( fig.1,2) . The peak increase of ALP was present at the concentration of 10 nM for ghrelin and 1nM for Hexarelin, while that of osteocalcin at the concentration of 1nM and 0,1-1nM, respectively
Our result would suggest that Hexarelin modulates osteoblast differentiation through an interaction with receptors for ghrelin, without interfering with cell proliferation. . Western blot analysis confirmed the expression of NR1 and NR2B proteins in RAdifferentiated cultures (RA). Bands corresponding to NR1 (~115 kDa) and NR2B (~180 kDa) were found in extracts from rat hippocampus, run in the same gel as positive control (data not shown).
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Fig. 3:
Glutamate-induced excitotoxicity. LDH release was assayed in control (open bars) and RA-treated (black bars) SK-N-SH cells exposed to glutamate (100-500 µM) for 15 min. No modification of LDH release was produced by glutamate in control cultures. In RA-treated cells glutamate caused a dose-dependent increase in extracellular LDH activity. This effect was prevented by 1 µM MK 801 but not by 1 µ M CNQX, both added 5 min before glutamate exposure. Application of 5 mM NMDA for 60 min in the presence of 10 µM glycine was also toxic to RA-differentiated cells. NMDA effect was prevented by 1 µM ifenprodil added 5 min before NMDA. Bars represent the means ± standard error of at least three experiments run in quadruplicate. Wilcoxon's rank sum test was used for the statistical analysis of values. * p < 0.01 versus basal value. 
CLOZAPINE-LIKE PROFILE OF THE CANNABINOID RECEPTOR ANTAGONIST SR141716A ON RODENT MODELS OF DEFICIENT SENSORIMOTOR GATING
Rizzetti M. C., Ratti C., Mazzoncini R., Bortolato M.*, Gessa G. L.* and Spano P. F. Schizophrenia is a disease involving deficits in one or more of the multiple mechanisms that enable normal individuals to filter or "gate" most of the sensory stimuli they receive. As a group such mechanisms are referred to as sensorimotor gating. Prepulse inhibition (PPI) of the startle reflex provides an operational measure of this and can be assessed across species using similar stimuli to elicit comparable response characteristics. The phenomenon of PPI occurs when brief non-startling acoustic, visual or tactile stimuli are presented 20-500 ms before the startling stimulus. PPI is known to be significantly reduced in schizophrenic patients and in rodents after one of the following pharmacological manipulations: stimulation of D2 dopamine receptors, using apomorphine or amphetamine; activation of serotonergic systems, by means of serotonin releasers or direct receptor agonists; blockade of NMDA receptors, using non-competitive antagonists such as phencyclidine (PCP), dizocilpine (MK-801) or ketamine. Disruption of PPI induced by NMDAreceptors antagonists has been used as an animal model of positive and negative symptoms of schizophrenia and previous studies indicate that atypical, but not typical, neuroleptics can selectively restore PPI in this model. Cannabinoids are known to have psychotropic effects in humans and clinical signs of chronic cannabis consumption may also resemble negative symptoms of schizophrenic disorders. The resulting suggestion that the etiology of schizophrenia may include an imbalance in endogenous cannabinoid signalling has led to the cannabinoid hypothesis of schizophrenia. On the bases of both this hypothesis and previous studies, showing that cannabinoids seem to act as dopaminergic and glutamatergic systems modulators, we have studied the effects of the cannabinoid CB1 receptors antagonist SR141716A on NMDA-antagonists-induced disruption of PPI. SR141716A was analyzed in 3 PPI paradigms: PCP-and MK-801-induced disruption of PPI, which have been shown to be preferentially reversed by antipsychotics, and apomorphine-induced disruption of PPI. From the analysis of the results of these experiments it appeared that SR141716A is able to significantly reverse both PCP-and MK-801-induced deficits in PPI while it has no effects on apomorphine-induced disruption.
Our data indicate that SR141716A is functionally similar to atypical antipsychotics, showing a clozapine-like profile that makes this substance a good candidate for further studies assessing its therapeutic potential in the treatment of schizophrenic patients. Our conclusion is also supported by preliminar experiments conducted in our laboratory and by previous findings that the blockade of cannabinoid CB1 receptors by SR141716A increases Fos-and neurotensin-like immunoreactivity with characteristics comparable to those reported for atypical antipsychotics such as clozapine.
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Effects of PCP and SR141716A on PPI: rats were treated with vheicle (1 ml/kg s.c.) + saline (1 ml/kg s.c.), vehicle (1 ml/kg s. The occurrence of low frequency (< 1.5 Hz) cerebral cortical oscillations during slow wave sleep (Steriade et al., 2001) has recently lead to the suggestion that this pattern of activity is specifically associated with conditions in which the brain is mostly closed to external inputs and running on its own (Timofeev et al., 1996a; Steriade, 2000, Destexhe and Sejnowski, 2001 ). In the current experiments we have used a combination of in vivo intracellular and extracellular field potential recordings obtained under conditions of ketamine/xylazine anesthesia to examine slow wave behavior in the olfactory system (Figure1). We demonstrate the occurrence of low frequency oscillations in field potentials of both the olfactory bulb and cortex and in the membrane potentials of cortical pyramidal cells. By monitoring ongoing breathing, we also show that these oscillations are all correlated with the natural breathing cycle ( Figure 1H ). Using a tracheotomized preparation, we demonstrate that the amplitude and regularity of the oscillations as well as their patterns of correlation are disrupted when air is no longer entering the nose. All temporal relationships were restored, however, when air was pulsed into the nostrils. We conclude that, in the olfactory system, there is a direct relationship between the occurrence and timing of slow oscillations and the ongoing periodic sensory input resulting from respiration. We believe this finding has important functional as well as evolutionary implications. Representative raw traces of pyramidal cell membrane potential (Vm), local field potentials in layer I of piriform cortex (PC), in granule cell layer of the olfactory bulb (OB), and respiratory wave as recorded from chest wall movements (Resp). All traces were recorded simultaneously. The vertical scale for the intracellular records is 10 mV, while the extracellular records are 1 mV. The graphs labeled B-E, indicate the power spectral density for the recorded membrane potentials (B), the local field potentials recorded in the piriform cortex (C), in the olfactory bulb (D), and ongoing respiration (E). F. Representative cross-covariance between membrane potential of a layer II/III pyramidal cell and layer I olfactory cortex local field potentials. G. Representative cross-covariance between membrane potential and local field potentials in the granule cell layer of the olfactory bulb. H. Respiratory-wave-triggered-average of membrane potential showing the dependence of membrane potential slow oscillations on respiratory phase.
